Download PDF
Der Nuklearmediziner 2009; 32(3): 237-244
DOI: 10.1055/s-0029-1234091
Nuklearmedizinische Labordiagnostik

© Georg Thieme Verlag KG Stuttgart · New York

Vitamin-D-Mangel und sekundärer Hyperparathyreoidismus im Ruhrgebiet (Nordrhein-Westfalen/Deutschland)

Upon Vitamin D Deficiency and Secondary Hyperparathyroidism in the Ruhr County (North-Rhine-Westphalia/Germany)J. Mahlstedt1 , D. Moka1
  • 1Gemeinschaftspraxen Radiologie/Nuklearmedizin, Essen
Further Information

Publication History

Publication Date:
23 September 2009 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Bei 2 500 unausgewählten Patienten einer nuklearmedizinischen Praxis im Ruhrgebiet wurde 25-(OH)-Vitamin-D-Unterversorgung (25–75 nmol/l) festgestellt bei Residenten/Immigranten in 55,6/30,1% und -Mangel (<25 nmol/l) bei 35,1/65,2%. Dementsprechend fanden sich erhöhte iPTH-Werte (>65 pg/ml) im Sinne des sekundären Hyperparathyreoidismus bei Residenten/Immigranten in 37/43,5%. Diese Abweichungen von der gewohnten Norm waren ausgeprägter bei >73 kg Körpergewicht. Vitamin-D-Mangel wirkt sich wegen seiner endokrinen (Ca-Stoffwechsel) und autokrinen/parakrinen Effekte (Muskelkraft, Infektresistenz, Wundheilung, Immunsystem usw.) auf die Entwicklung der Körpergewebe sehr ungünstig aus, sodass die Patienten zuerst auf die sinnvolle Nutzung des Sonnenlichtes aufmerksam gemacht werden müssen. Dafür wurden Informationsschriften in allen relevanten Sprachen entwickelt. Zur medikamentösen Substitution im Sinne der Prävention sind 1 000–2 000 IE Vitamin D3/Tag erforderlich, die Dosierung ist bei gesunden Menschen nach derzeitiger Expertenmeinung unbedenklich. Für die volle Prävention ist nach diesen Daten für das Ruhrgebiet ein 25-(OH)-Vitamin-D-Wert von >100 nmol/l erforderlich

Abstract

In 2 500 unselected patients of an outpatient nuclear medical practice in the Ruhr county (Germany) 25-(OH)-vitamin D insufficiency (25–75 nmol/l) was found in resident/immigrant subjects in 55,6/30,1 % and deficiency (<25 nmol/l) in 35,1/65,2%) concomitant with increased intact parathyroid hormone as a sign of secondary hyperparathyroidism in 37/43,5%. These deviations from normal were more intensive at >73 kg bodyweight. Vitamin D deficiency exerts severe negative influence on all body tissues because of its endocrine (calcium metabolism) and paracrine/autocrine (muscle tension, infect resistance, skin lesion healing, immune system etc.) effects. Therefore patients receive information for the prudent use of sunlight and substitution by tablets or oily solutions with the help of a special information flyer available in all relevant languages. The recommendation for prevention of vitamin D insufficiency und -deficiency for so far healthy subjects is 1 000–2 000 IE vitamin D3/day, the dosage being without of harm according to relevant experts meaning. For full prevention in the Ruhr county of Germany serum 25-(OH)-vitamin D levels should exceed 100 nmol/l.

Schlüsselwörter

Vitamin-D-Unterversorgung - Vitamin-D-Mangel - sekundärer Hyperparathyreoidismus

Key words

vitamin D insufficiency - vitamin D deficiency - secondary hyperparathyroidism

Literatur

  • 1 Abbas S, Chang-Claude J, Lindeisen J. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study.  Int J Cancer. 2009;  124 250-255
    CrossrefPubMedGoogle Scholar
  • 2 Arvold DS, Odean MJ, Dornfeld MP. et al . Correlation of symptoms with vitamin d deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial.  Endocr Pract. 2009;  15 203-212
    PubMedGoogle Scholar
  • 3 Badsha H, Daher M, Ooi Kong K. Myalgias or non-specific muscle pain in Arab or Indo-Pakistani patients may indicate vitamin D deficiency. Clin Rheumatol. Elektr. Publikation PMID19277814
    PubMedGoogle Scholar
  • 4 Benitez-Aguirre PZ, Wood NJ, Biesheuvel C. et al . The natural history of vitamin D deficiency in African refugees living in Sydney.  Med J Aust. 2009;  190 426-428
    PubMedGoogle Scholar
  • 5 Benjamin A, Moriakova A, Akhter N. et al .Determinants of 25-hydroxyvitamin D levels in African-American and Caucasian male veterans. Osteoporos Int. 2009 Elektr. Publikation PNID 19280273
    PubMedGoogle Scholar
  • 6 Bikle DD, Oda Y, Xie Z. Calcium and 1,25(OH)2D: interacting drivers of epidermal differentiation.  J Steroid Biochem Mol Biol. 2004;  90 355-360
    CrossrefPubMedGoogle Scholar
  • 7 Bischoff-Ferrari HA, Giovannucci E, Willett WC. et al . Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes.  Am J Clin Nutr. 2006;  84 18-28
    CrossrefPubMedGoogle Scholar
  • 8 Bischoff-Ferrari HA, Willett WC, Wong JB. et al . Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials.  Arch Intern Med. 2009;  169 551-561▪
    CrossrefPubMedGoogle Scholar
  • 9 Bischoff-Ferrari HA. How to select the doses of vitamin D in the management of osteoporosis.  Osteoporos Int. 2007;  18 401-407
    CrossrefPubMedGoogle Scholar
  • 10 Bischoff-Ferrari HA. The 25-hydroxyvitamin D threshold for better health.  J Steroid Biochem Mol Biol. 2007;  103 614-619
    CrossrefPubMedGoogle Scholar
  • 11 Bodnar LM, Catov JM, Simhan HN. et al . Maternal Vitamin D Deficiency Increases the Risk of Preeclampsia.  J Clin Endocrinol Metab. 2007;  92 3517-3522
    CrossrefPubMedGoogle Scholar
  • 12 Bodnar LM,  MA, Simhan HN. et al . Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy.  J Nutr. 2009;  139 ((6)) 1157-1161
    CrossrefPubMedGoogle Scholar
  • 13 Cannell JJ, Hollis BW, Sorenson MB. et al . Athletic performance and vitamin D.  Med Sci Sports Exerc. 2009;  41 1102-1110
    PubMedGoogle Scholar
  • 14 Chan J, Jaceldo-Siegl K, Fraser GE. Serum 25-hydroxyvitamin D status of vegetarians, partial vegetarians, and nonvegetarians: the Adventist Health Study-2.  Am J Clin Nutr. 2009;  89 1686-1692
    CrossrefPubMedGoogle Scholar
  • 15 Chromek M, Slamova Z, Bergmann P. et al . The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection.  Nat Med. 2006;  12 636-641
    CrossrefPubMedGoogle Scholar
  • 16 Cross HS, Kallay E. Regulation of the colonic vitamin D system for prevention of tumor progression: an update.  Future Oncol. 2009;  5 493-507
    CrossrefPubMedGoogle Scholar
  • 17 Dawson-Hughes B, Heany RP, Holick MF. et al . Estimates of optimal vitamin D status.  Osteoporos Int. 2005;  16 713-716
    CrossrefPubMedGoogle Scholar
  • 18 Daoudi N, Karmali R, Fuss M. et al . Evaluation of vitamin D deficiency in hospitalized patients in Brussels.  Rev Med Brux. 2009;  30 5-10
    PubMedGoogle Scholar
  • 19 Ding C, Cicuttini F, Parameswaran V. Serum levels of vitamin D, sunlight exposure, and knee cartilage loss in older adults: the Tasmanian older adult cohort study.  Arthritis Rheum. 2009;  60 1381-1389
    CrossrefPubMedGoogle Scholar
  • 20 Dobnig H, Pilz S, Scharnagel H. et al . Independent Association of Low Serum 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Levels with all-cause and Cardiovascular Mortality.  Arch Int Med. 2008;  168 1340-1349
    CrossrefPubMedGoogle Scholar
  • 21 Fahrleitner A, Dobnig H, Obernosterer A. et al . Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease.  J Gen Intern Med. 2002;  17 663-669
    CrossrefPubMedGoogle Scholar
  • 22 Foo LHh, Zhang Q, Zhu K. et al . Low vitamin D status has an adverse influence on bone mass, bone turnover, and muscle strength in Chinese adolescent girls.  J Nutr. 2009;  139 1002-1007▪
    PubMedGoogle Scholar
  • 23 Forouhi NG. Baseline serum 25-hydroxyvitamin D is predictive of future glycemic status and insulin resistance: the Medical Research CouncilEly Prospective Study 1990–2000.  Diabetes. 2008;  57 2619-2625
    CrossrefPubMedGoogle Scholar
  • 24 Fu L, Yun F, Oczak M. et al . Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation.  Clin Biochem. 2009;  42 1174-1177
    CrossrefPubMedGoogle Scholar
  • 25 Genuis SJ, Schwalfenberg GK, Hiltz MN. et al . Vitamin D status of clinical practice populations at higher latitudes: analysis and applications.  Int J Environ Res Public Health. 2009;  6 151-173
    CrossrefPubMedGoogle Scholar
  • 26 Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004.  Arch Intern Med. 2009;  23 626-632
    PubMedGoogle Scholar
  • 27 Gorham ED, Garland CF, Garland FC. et al . Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis.  Am J Prev Med. 2007;  32 210-216
    CrossrefPubMedGoogle Scholar
  • 28 Grant WB, Cross HS, Garland CF. et al .Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe. Prog Biophys Mol Biol. 2009 Elekt. Publikation PM19268496
    PubMedGoogle Scholar
  • 29 Hase K, Eckmann L, Leopard JD. et al . Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium.  Infect Immun. 2002;  70 953-963
    CrossrefPubMedGoogle Scholar
  • 30 Haugen M, Brantsæter AL, Trogstad L. et al .Vitamin D Supplementation and Reduced Risk of Preeclampsia in Nulliparous Women. Epidemiology. 2009 Elektr. Publication PMID 19451820
    PubMedGoogle Scholar
  • 31 Heany RP. Serum 25-hydroxyvitamin D and parathyroid hormone exhibit threshold behavior.  J Endocrinol Invest. 2005;  28 180-182
    PubMedGoogle Scholar
  • 32 Hill TR, Cotter AA, Mitchell S. et al .Vitamin D status and parathyroid hormone relationship in adolescents and its association with bone health parameters: analysis of the Northern Ireland Young Heart's Project. Osteoporos Int. 2009 Elektr. Publikation PMID 19436930
    PubMedGoogle Scholar
  • 33 Hintzpeter B, Mensink GBM, Thierfelder W. et al . Vitamin D status and health correlates among German adults.  Eur J Clin Nutr. 2008;  62 1079-1089
    CrossrefPubMedGoogle Scholar
  • 34 Holick MF. Vitamin D Deficiency.  N Engl J Med. 2007;  357 266-281
    CrossrefPubMedGoogle Scholar
  • 35 Hypponen E. Intake of vitamin D and risk of type 1 diabetes: a birth cohort study.  Lancet. 2001;  358 1500-1503
    CrossrefPubMedGoogle Scholar
  • 36 Kull M, Kallikorm R, Lember M. Body mass index determines sunbathing habits: implications on vitamin D levels.  Intern Med J. 2009;  39 256-258
    CrossrefPubMedGoogle Scholar
  • 37 Lappe JM, Travers-Gustafson D, Davies KM. et al . Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial.  Am J Clin Nutr. 2007;  85 1586-1591
    PubMedGoogle Scholar
  • 38 Lucas RM, Ponsonby AL. Considering the potential benefits as well as adverse effects of sun exposure: can all the potential benefits be provided by oral vitamin D supplementation?.  Prog Biophys Mol Biol.. 2006;  92 140-149
    CrossrefPubMedGoogle Scholar
  • 39 Maalouf J, Nabulsi M, Vieth R. et al . Short Term and long term safety of weekly high dose vitamin D3 supplementation in school children.  J Clin Endocrin Metab. 2008;  93 2693-2701
    PubMedGoogle Scholar
  • 40 Mona S, Calvo MS, Whiting SJ. et al . Vitamin D intake: a global perspective of current status.  J Nutr. 2006;  135 310-316
    PubMedGoogle Scholar
  • 41 Mühlebach S, Bischoff-Ferrari HA. Myalgia and proximal muscle weakness in a young patient.  Praxis (Bern 1994). 2009;  98 447-450
    CrossrefPubMedGoogle Scholar
  • 42 Osmancevic A, Nilsen LT, Landin-Wilhelmsen K. et al .Effect of climate therapy at Gran Canaria on vitamin D production, blood glucose and lipids in patients with psoriasis. J Eur Acad Dermatol Venereol. Elektr. Publikation PMID19453805
    PubMedGoogle Scholar
  • 43 Pramyothin PS, Techasurungkul J, Lin J. et al .Vitamin D status and falls, frailty, and fractures among postmenopausal Japanese women living in Hawaii. Osteoporos Int. 2009 Elektr. Publikation PM19308301
    PubMedGoogle Scholar
  • 44 Reichrath J, Nürnberg B. Vitamin-D-Mangel: ein Thema für die Volksgesundheit in Europa.  J Klin Endokrinol Stoffk. 2009;  2 22-25
    PubMedGoogle Scholar
  • 45 Schauber J, Dorschner RA, Coda AB. et al . Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism.  J Clin Invest. 2007;  117 803-811
    CrossrefPubMedGoogle Scholar
  • 46 Schmidt M, Thoma N, Dietlein M. et al . 99mTc-MIBI in primary Hyperparathyroidism – influence of concomitant vitamin D deficiency for visualization of parathyroid adenomas.  Nuklearmedizin. 2008;  47 1-7
    PubMedGoogle Scholar
  • 47 Tjabringa GS, Rabe KF, Hiemstra PS. The human cathelicidin LL 37: a multifunctional peptide involved in infection an d inflammation in the lung.  Pulm Pharmacol Ther. 2005;  18 321-327
    CrossrefPubMedGoogle Scholar
  • 48 Webb AR. Who, what, where and when – influences on cutaneous vitamin D synthesis.  Progr. Biophys. Mol Biol. 2006;  92 17-25
    PubMedGoogle Scholar
  • 49 Vieth R, Bischoff-Ferrari H, Boucher BJ. et al . The urgent need to recommend an intake of vitamin D that is effective.  Am J Clin Nutr. 2007;  85 649-650
    PubMedGoogle Scholar
  • 50 Winters SJ, Chennubhatla R, Wang C. Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in African American and white women.  Metabolism.. 2009;  58 438-442
    CrossrefPubMedGoogle Scholar
  • 51 Zipitis CS. Vitamin D supplementationin early childhood and risk of type 1 diabetes: a systematic review and meta-analysis.  Arch Dis Child. 2008;  93 512-517
    CrossrefPubMedGoogle Scholar
  • 52 Zaiou M, Gallo RL. Cathelicidins, essential gene-encoded mammalian antibiotics.  J Mol Med. 2002;  80 549-561
    CrossrefPubMedGoogle Scholar
  • 53 Zanetti M. The role of cathelicidins in the innate host defenses of mammals.  Curr Issues Mol Biol.. 2005;  7 179-196
    PubMedGoogle Scholar
  • 54 Zittermann A, Frisch S, Berthold HK. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers.  Am J Clin Nutr. 2009;  89 1321-1327
    CrossrefPubMedGoogle Scholar

Korrespondenzadresse

Prof. Dr. Jörg Mahlstedt

Gemeinschaftspraxis

Nuklearmedizin

Henricistraße 40

45136 Essen

Email: pm@profmahlstedt.de

URL: http://www.radionuk.de

      >